Endo Pharmaceuticals’ Testosterone Gel Wins Approval

Endo Pharmaceuticals Holdings Inc., the maker of pain medications, won U.S. approval to sell Fortesta, a testosterone replacement therapy for men.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.